Footwear for diabetic patients Growing market opportunities for footwear companies

The World Health Organisation (WHO) reports that approximately 27% of diabetic patients are exposed to the peripheral neuropathies, among which more than 50% of those have injuries in the legs. According to the WHO forecasts, 51% of people with diabetes worldwide will eventually develop diabetic neuropathy. This means that, inevitably, the diabetic footwear market is expected to spike in coming years: the Diabetic Footwear Global Market Report 2023 suggests that the market reached $7.83 billion in 2023, and will further grow to 10,67 billion $ in 2027, meaning a compound annual growth rate (CAGR) of 8.1%.

Share linkedin facebook Twitter